Science
Senior Business Development Manager
Last updated
Senior Business Development Managers identify, negotiate, and close strategic partnerships, licensing agreements, and alliances that expand a company's commercial reach, technology portfolio, or market position. In science-intensive industries like pharmaceuticals, biotech, and scientific instruments, they combine deal-making skill with technical literacy to evaluate opportunities and negotiate terms that reflect the real value of assets being transacted.
Role at a glance
- Typical education
- Advanced degree in life sciences (PhD, MD, PharmD) plus MBA, or MBA with science/healthcare experience
- Typical experience
- 5-8+ years
- Key certifications
- None typically required
- Top employer types
- Pharmaceutical companies, biotechnology firms, medtech companies, diagnostics companies, agricultural biotechnology
- Growth outlook
- Stable demand driven by structural pharmaceutical dependence on in-licensing and acquisitions
- AI impact (through 2030)
- Augmentation and expanded demand — AI-based drug discovery is creating new transaction structures and increasing the need for managers who can evaluate AI-driven platform technologies.
Duties and responsibilities
- Identify and evaluate external partnership and licensing opportunities that align with company strategy and fill pipeline or technology gaps
- Lead due diligence assessments of potential acquisition targets, in-license candidates, and strategic partners
- Build and maintain relationships with business development counterparts at pharmaceutical, biotech, and technology companies
- Negotiate term sheets, licensing agreements, collaboration contracts, and co-promotion arrangements
- Prepare deal analyses including NPV models, milestone structures, royalty rate assessments, and risk-adjusted valuations
- Lead internal cross-functional teams — legal, finance, clinical, regulatory, R&D — through deal evaluation and transaction execution
- Present deal opportunities and recommendations to senior leadership and corporate development committees
- Monitor the competitive landscape and emerging technologies relevant to the company's strategic focus areas
- Manage relationships with existing partners including joint steering committee participation and milestone tracking
- Represent the company at industry conferences, investor days, and partnering events to source and maintain relationships
Overview
A Senior Business Development Manager in a science-intensive company is part deal-maker, part strategy analyst, and part scientist — depending on the deal under discussion. Their job is to expand the company's value by finding, evaluating, and executing transactions that give the company access to technologies, products, or markets it couldn't reach as efficiently on its own.
In the pharmaceutical and biotech context, that typically means in-licensing clinical-stage assets from smaller biotechs or academic spinouts, negotiating co-development or co-commercialization agreements, managing existing collaboration relationships, and occasionally working on acquisitions. Each of these activities requires a distinct skill set that the Senior BD Manager combines: technical literacy to evaluate whether an asset's clinical data is compelling, financial skills to build a credible NPV model, negotiating skill to reach deal terms that reflect fair value, and project management ability to drive a complex multi-functional process to close.
The deal sourcing work is largely relationship-driven. Senior BD managers build and maintain a network across the industry — scientists and executives at potential partners, venture investors in the relevant space, academic technology transfer offices, and financial advisers who work on transactions. They attend the major partnering conferences — BIO, JP Morgan Healthcare, ASCO, ASH — specifically to maintain existing relationships and develop new ones. The best deals often come from relationships that were built years before the asset was ready to transact.
Deal execution requires coordinating legal, finance, R&D, regulatory, and commercial functions through a process that can run from months for straightforward licenses to years for complex multi-asset collaborations. The BD manager is the orchestrator who keeps that process moving without losing the counterpart's interest or missing the window when terms are most favorable.
Qualifications
Education:
- Advanced degree in a life science or technical field (PhD, MD, PharmD) plus MBA — this is the strongest credential combination for senior pharma/biotech BD roles
- MBA alone from a top-ranked program with 3–5 years in a science or healthcare context
- Some companies value extensive industry experience over specific degree combinations at the senior level
Deal and transaction experience:
- 5–8+ years in pharmaceutical/biotech/medtech BD, investment banking (healthcare focus), or consulting with BD execution experience
- Track record of completed transactions — deals signed and closed, not just evaluated
- Experience with the full deal lifecycle: sourcing, due diligence, term sheet negotiation, definitive agreement, integration or milestone management
Technical and analytical skills:
- Financial modeling: DCF/NPV valuation of drug assets, scenario analysis, milestone and royalty modeling
- Scientific due diligence: ability to critically evaluate Phase I/II clinical data, mechanism of action, competitive positioning
- IP assessment: reading patent landscapes, understanding freedom-to-operate basics (not at attorney level, but enough to engage intelligently)
- Contract basics: term sheet structure, licensing provisions, milestone definitions, change-of-control clauses
Relationship and negotiation skills:
- Active network in the relevant industry sectors — conferences, working groups, professional associations
- Negotiation experience at the term sheet and definitive agreement level
- Cross-functional leadership — running internal deal teams without direct authority over participants
Tools:
- Financial modeling in Excel
- CRM systems for relationship tracking
- Data rooms and M&A due diligence platforms (Intralinks, Ansarada, ShareVault)
Career outlook
Business development roles in science-intensive industries sit at a convergence point between scientific, financial, and commercial skills that is genuinely rare and durably valuable. The supply of people who can credibly evaluate a Phase II asset's clinical data, build a deal model that senior management trusts, and negotiate terms with a sophisticated counterpart is limited — which keeps compensation at the senior level competitive.
The pharmaceutical and biotech transaction market has been consistently active, with licensing deal volume largely tracking R&D investment cycles. Large pharmaceutical companies depend on BD to supplement internal pipelines — the reality of pharmaceutical economics is that no single company can discover enough drugs internally to sustain its commercial operations. That structural dependence on in-licensing and acquisitions ensures that BD organizations at major companies are resourced and valued.
AI-based drug discovery has expanded the universe of potential BD partners and created new transaction structures. Large pharma companies have signed hundreds of AI-platform collaborations in the last several years, and evaluating these opportunities — which require assessing both clinical assets and platform technology quality — is creating new BD skill requirements. Senior managers who develop fluency in evaluating AI-driven discovery platforms have early-mover advantage in a deal type that will be more common going forward.
The medtech and diagnostics sectors have parallel BD functions with similar skill requirements and comparable compensation. Agricultural biotechnology, specialty chemicals, and scientific instrumentation also have BD functions, though typically at lower salary levels than pharmaceutical and biotech.
Career advancement leads to VP of Business Development, Chief Business Officer, or in some cases Chief Executive Officer — the BD track is one of the more credible paths to C-suite roles at smaller biotech companies, where dealmaking is a core CEO function. BD Directors at large pharma earn $200K–$260K with bonus; CBOs at mid-size biotechs can earn comparable amounts with meaningful equity.
Sample cover letter
Dear Hiring Manager,
I'm applying for the Senior Business Development Manager position at [Company]. I have six years in pharmaceutical business development — two years as an analyst at [Bank/Consulting firm] covering healthcare transactions, and the past four years in BD at [Company], where I've been involved in seven completed transactions including three in-licensing deals, one co-development agreement, and three research collaboration agreements.
The deal I'm most proud of was an in-licensing transaction for a Phase II bispecific antibody in [therapeutic area]. I identified the asset through a conference relationship I'd been developing with the company's CMO for two years, led the scientific due diligence with our clinical and regulatory teams, built the deal model under several development and commercial scenarios, and negotiated the term sheet through four rounds. The deal closed at terms that reflected the asset's genuine value without overpaying — the head of R&D specifically commented that the due diligence package I put together was the most rigorous she'd seen on an externally sourced asset.
I've built a meaningful network in the [therapeutic area] space through consistent conference engagement and follow-through on relationships. Several of our recent deal opportunities came through contacts I'd been cultivating for 18 months or more before the asset was ready to transact.
I'm interested in [Company] because of your stated strategic focus on [therapeutic area or technology platform], which aligns with the relationships and market knowledge I've built. I'd welcome the chance to discuss how my background fits.
[Your Name]
Frequently asked questions
- What background do successful pharma/biotech business development managers come from?
- Most come from one of three backgrounds: scientific or medical backgrounds (PhD, MD, or PharmD) combined with an MBA or finance training; investment banking or consulting backgrounds who moved into industry BD; or internal commercial or regulatory roles who developed BD skills on the job. The scientific background is particularly valued in early-stage asset transactions where technical due diligence is the core of the evaluation.
- What is a deal structure in biotech licensing, and what are typical components?
- A licensing deal structure typically includes an upfront payment (paid at signing), development milestones (paid when the asset reaches defined regulatory or clinical events), sales milestones (paid when products hit commercial revenue thresholds), and royalties on net sales. The ratio of upfront to backend value is a major negotiating point — licensors prefer front-loaded deals; licensees prefer backend-heavy structures that reduce initial cash outlay.
- What is BD due diligence and what does it cover?
- Due diligence in a potential in-licensing or acquisition context involves evaluating the target asset's clinical data (Is the efficacy compelling? Are the safety signals manageable?), regulatory status (What is the path to approval?), intellectual property (Is the patent estate defensible? What is the freedom to operate?), market opportunity, and manufacturing feasibility. The BD manager coordinates subject matter experts in each area and synthesizes their assessments into a deal recommendation.
- How has the partnering landscape changed with AI drug discovery platforms?
- AI-driven drug discovery companies have become significant BD counterparties for large pharmaceutical companies. Deals with companies like Recursion, Insilico Medicine, and various platform companies involve new structures — research collaborations with option-to-license rights on discovered compounds — that differ from traditional asset-based licensing. Evaluating these partnerships requires assessing the quality and generalizability of AI platforms, not just individual asset data, which adds technical complexity.
- Is an MBA necessary for business development roles in life sciences?
- An MBA from a top program is a significant credential for BD roles at large pharmaceutical companies and is often listed as required or strongly preferred. It provides the financial modeling, deal structuring, and negotiation training that are core to the role. However, scientists with PhDs and self-taught financial skills who've developed BD track records at smaller companies sometimes successfully compete for roles where that experience outweighs the credential. The MBA matters most for hiring into structured BD programs at large companies.
More in Science
See all Science jobs →- Senior Biostatistician$105K–$155K
Senior Biostatisticians lead the statistical design and analysis of clinical trials and biomedical research studies. They own the statistical analysis plans for pivotal trials, oversee the integrity of trial data, contribute to regulatory submissions, and provide the quantitative expertise that connects clinical evidence to regulatory approval and medical practice.
- Senior Clinical Research Associate$85K–$125K
Senior Clinical Research Associates monitor clinical trial sites to ensure study protocols are followed, patient data is accurate, and regulatory requirements are met. They operate independently across a site portfolio, mentor junior CRAs, and serve as the primary sponsor or CRO contact for the sites they oversee — carrying accountability for data quality and regulatory compliance at those sites.
- Senior Analytical Chemist$88K–$130K
Senior Analytical Chemists lead method development and validation projects, provide technical leadership on complex analytical problems, and serve as the resident experts on analytical techniques within their group. They combine deep instrument proficiency with the regulatory and scientific judgment to ensure that analytical data is reliable, defensible, and appropriate for its intended purpose.
- Senior Clinical Research Coordinator$62K–$95K
Senior Clinical Research Coordinators manage the day-to-day conduct of clinical trials at research sites — coordinating patient visits, maintaining regulatory documents, ensuring GCP compliance, and serving as the primary contact between the site and the sponsoring pharmaceutical company or CRO. They carry full accountability for their studies without requiring supervision and often train and oversee junior coordinators.
- Clinical Trial Manager$90K–$132K
Clinical Trial Managers oversee the operational execution of one or more clinical trials, managing study startup, site networks, CRO performance, enrollment timelines, and data quality from protocol activation through database lock. They lead cross-functional study teams and are the primary accountability point for a trial's schedule, budget, and GCP compliance.
- Process Technician$42K–$70K
Process Technicians operate and monitor manufacturing equipment and processes in production facilities — executing procedures, collecting process data, and ensuring that production runs within specified parameters. They are the hands-on operators who translate process engineering designs into actual manufactured product, following documented procedures in regulated or industrial manufacturing environments.